Takuro Miyazaki

Takuro Miyazaki

Department of Biochemistry, Showa University School of Medicine

Affiliated withShowa University School of Medicine

Research Area

Biography

Takuro Miyazaki is an associate professor in the Department of Biochemistry, Showa University School of Medicine in Tokyo, Japan. He received his undergraduate from Showa University School of Pharmacy. He obtained His Ph.D. in 2009 from Showa University School of Pharmacy, with a thesis on calcium homeostasis and mechanotransduction in vascular endothelial cells. In 2011, he was recruited as faculty at Showa University School of Medicine.

His research interests are the field of intracellular protein catabolism, in particular their impact on vascular functions. He discovered that calpain-2, an intracellular calcium-dependent protease, in vascular endothelial cells associates with the pathogenesis of atherosclerosis (Miyazaki T et al. Circulation. 2011;124:2522-2532), and identified that calpain dysregulation is responsible for pathological angiogenesis, such as tumor angiogenesis and retinopathy (Miyazaki T et al. Circ Res. 2015;116:1170-1181). More recent, he identified that calpain-6, an atypical non-proteolytic calpain, participates in cholesterol uptake in macrophages, thereby accelerating atherosclerosis development (Miyazaki T et al. J Clin Invest. 2016;126:3417-3432).

His work has been awarded with several prestigious prizes, among them the Young Investigator’s Award of the Japan Atherosclerosis Society in 2012 and the Young Investigator’s Award of the Japanese Vascular Biology and Medicine Organization in 2013. He is councilor of the Japan Atherosclerosis Society and the Japanese Vascular Biology and Medicine Organization.

JoVE Journal Publications

ArticleTotal : 1
Year
Evaluation of Protein–Protein Interactions using an On-Membrane Digestion Technique
Publication title

Cited by 1

2019

Other Publications

Article
Year
[Flow-induced Ca2+ transients regulate morphological changes in vascular endothelial cells via calpain-mediated proteolytic cleavage].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica| PubMed ID: 16327206

2005
2007
2007
2010
2011
2011
2012
2012
Calpain and atherosclerosis.

Journal of atherosclerosis and thrombosis| PubMed ID: 23171729

2013
2014
NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice.

Arteriosclerosis, thrombosis, and vascular biology| PubMed ID: 25189573

2014
2015
2015
2016
2016
Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases.

Journal of atherosclerosis and thrombosis| PubMed ID: 27476665

2017
Calpain-6 confers atherogenicity to macrophages by dysregulating pre-mRNA splicing.

The Journal of clinical investigation| PubMed ID: 27525442

2016
Emerging roles of calpain proteolytic systems in macrophage cholesterol handling.

Cellular and molecular life sciences : CMLS| PubMed ID: 28432377

2017
Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders.

Journal of atherosclerosis and thrombosis| PubMed ID: 28819082

2018
2018
2018
2019
Endothelial calpain systems orchestrate myofibroblast differentiation during wound healing.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 30199285

2019
L-Leucine increases the daily body temperature and affords thermotolerance in broiler chicks.

Asian-Australasian journal of animal sciences| PubMed ID: 30381734

2019
Thrombolytic Therapy for Acute Ischemic Stroke: Past and Future.

Current pharmaceutical design| PubMed ID: 30892155

2019